Colorectal Cancer Screening Trends Shift Post-COVID, Disparities Remain
October 21, 2025 – A significant alteration in colorectal cancer (CRC) screening practices has been observed among nearly 25 million insured adults following the outbreak of the COVID-19 pandemic. Recent analyses demonstrate a decrease in colonoscopy and fecal immunochemical test (FIT) utilization, contrasted by a marked increase in the use of stool DNA testing.The extensive study, findings of which were released this month, also highlights continuing differences in screening choices related to gender, socioeconomic standing, and geographic location.
Shifts in Screening Modalities
Researchers examined data spanning from 2017 to 2024, finding a clear trend. Colonoscopy usage decreased from 1.29% to 1.14%, while FIT adoption dropped from 0.54% to 0.38%. Conversely, stool DNA tests saw a substantial surge, climbing from 0.19% to 0.61%. These alterations likely reflect pandemic-related disruptions to healthcare access and a greater preference for at-home testing options.
Disparities in Access and Preference
The study uncovered critical disparities in screening practices. Men were found to be more inclined towards colonoscopies,while women favored stool DNA tests and FIT kits. Individuals from higher socioeconomic backgrounds exhibited greater use of both colonoscopies and stool DNA tests, but less reliance on FIT tests, compared to those with lower incomes. Residents of metropolitan areas more frequently opted for colonoscopies and FIT, while stool DNA test utilization appeared consistent between urban and rural populations.
A Closer Look at the Data
| Screening Modality | Pre-Pandemic (2017-2020) | Post-Pandemic (2020-2024) | Change |
|---|---|---|---|
| Colonoscopy | 1.29% | 1.14% | -0.15% |
| FIT | 0.54% | 0.38% | -0.16% |
| Stool DNA Test | 0.19% | 0.61% | +0.42% |
Did You Know? Colorectal cancer is the second leading cause of cancer deaths in the united States, but is highly preventable with regular screening.
Limitations and Future Research
The researchers acknowledge that the data, drawn from Blue Cross Blue Shield (BCBS) beneficiaries, may not fully represent the broader U.S. population. Factors such as age, insurance coverage, and geographic distribution within the BCBS system could influence the results. Moreover, the absence of test result data prevents definitive conclusions about screening adherence.
Pro Tip: Discuss your colorectal cancer screening options with your doctor to determine the most appropriate method for your individual risk factors and preferences.
The Ongoing Impact of COVID-19
The study reinforces the understanding that the COVID-19 pandemic significantly impacted preventative healthcare services. While the shift towards at-home testing offers convenience, it also raises questions about equitable access and the potential for missed diagnoses. addressing the disparities in screening rates remains a crucial public health priority.
Understanding Colorectal Cancer
Colorectal cancer develops when abnormal cells grow in the colon or rectum. Early detection is vital for successful treatment.symptoms can include changes in bowel habits, rectal bleeding, abdominal discomfort, and unexplained weight loss. the American Cancer Society provides comprehensive resources on prevention,detection,and treatment.
Regular screening, starting at age 45 for individuals at average risk, is the most effective way to prevent colorectal cancer. Screening tests can detect precancerous polyps, which can be removed before they develop into cancer.
Frequently Asked Questions About Colorectal Cancer Screening
- What is the best colorectal cancer screening test? The most appropriate test depends on individual factors and should be discussed with a healthcare provider.
- How often should I get screened for colorectal cancer? Guidelines recommend screening starting at age 45, with the frequency depending on the test type and individual risk.
- Are at-home stool tests as effective as colonoscopies? Stool DNA tests can be highly accurate, but a positive result typically requires a follow-up colonoscopy.
- What are the risk factors for colorectal cancer? Risk factors include age, family history, inflammatory bowel disease, and certain lifestyle factors.
- Why is early detection of colorectal cancer important? Early detection significantly increases the chances of successful treatment and survival.
- Can I get colorectal cancer if I have no symptoms? Yes, colorectal cancer often has no symptoms in its early stages, highlighting the importance of regular screening.
What factors do you believe are most hindering people from getting screened for colorectal cancer? Share your thoughts in the comments below!
